Cell Signaling Technology Applies MS-Based Proteomics and Next-Gen Sequencing to Antibody Production | GenomeWeb

By Adam Bonislawski

Researchers at biotech company Cell Signaling Technology have developed an antibody-production method that uses a combination of mass spec-based proteomics and next-generation sequencing to identify antigen-specific antibody sequences in the serum of immunized animals.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.